For a while there this weekend, it had seemed that the upcoming adult stem cell meeting in Houston keynoted by Guv Rick Perry had lost something important. Its website! Oops. Now that all seems fixed. Whew. However, a second stem cell-related entity seems to have made the same mistake, but this time it appears likely […]
Another stem cell website goof: ICMS loses its patient website Read More »
The International Cellular Medicine Society (ICMS) is viewed somewhat skeptically by the stem cell community, but they are undeniably an important player in the stem cell world. A few weeks ago I interviewed ICMS President, Dr. Ricardo Rodriguez (see interview here), and then I provided recommendations here to the ICMS to improve their organization including a less adversarial
ICMS posts 483 report of FDA audit: still awaiting news on Celltex Read More »
The FDA has been busy with stem cell-related activities this spring including with ICMS. Busier than publicly apparent. Very busy, indeed! Earlier, I reported that they issued a warning letter to cosmetician to the stars, Dr. LookGood, as well as one to another doc selling stem cell therapies. Now it seems apparent that even more
FDA visits both ICMS and reportedly Celltex Read More »
Yesterday I did an interview with the President of ICMS and then today I did a follow-up post providing my recommendations to them publicly on how they should move forward. Why did I do this? Or to paraphrase a stem cell scientist who just now let me have it: “Why the #*@#$&^# did you do
Why did I have a dialogue with ICMS? Read More »
Yesterday I posted an interesting interview with ICMS President Dr. Ricardo Rodriguez. I again thank Rodriguez for participating. Please note that one issue that I had already raised to Dr. Rodriguez was that I could not find the membership of their IRB listed on their website and this was apparently just addressed as that information can
Recommendations to ICMS for improved practices Read More »
The International Cellular Medicine Society (ICMS) has emerged as an important organization related to stem cell regulatory issues. I think that many people do not understand what ICMS is all about and it certainly evokes strong opinions in the stem cell field. If you care about stem cells then you need to know about ICMS
ICMS President Rodriguez interview on adult stem cell regulatory issues Read More »
Could the blinding of three women at a stem cell clinic have been prevented by better oversight or was the clinic acting outside of the scope of oversight by its institutional review board (IRB)? More broadly, when is an IRB conducting proper oversight and how do we know? When on the other hand is it
Does stem cell clinic IRB approval mean much? Insights from blinding cases Read More »
Who is Doug Broeska and what is Regenetek a Canadian stem cell company doing that is drawing attention of authorities? The Winnipeg Free Press is reporting that Regenetek faces serious charges related to for-profit stem cell therapies. (Update: a followup story in the Free Press has been published). A very thorough article in the newspaper
Stem cell clinic & Doug Broeska face stem cell fraud allegations Read More »
The Cell Surgical Network is a for-profit network of clinics offering various stem cell-related interventions, which began with the California Stem Cell Treatment Center. I have interviewed Drs. Elliot Lander and Mark Berman of the Network in past (Part 1, Part 2) and I raised some concerns about the network in a follow up Part 3 post,
Update on Cell Surgical Network IRB Status Read More »
I recently interviewed Drs. Elliot Lander and Mark Berman of the Cell Surgical Network. It’s an affiliated chain of clinics selling stem cell interventions for more than a dozen medical conditions. You can read Part 1 here and Part 2 here of the interview where we cover 10 important questions. Today is Part 3, where I explain why their answers
Cell Surgical Network Series Part 3: Key Concerns Read More »